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THE SILENCE OF HEALTH
“Health is life lived in the silence of the
organs” wrote the French surgeon René
Leriche in 1936, a concept later adopted
and further developed by the physician
and philosopher Georges Canguilhem (1).
Albeit certainly resonant with the expe-
rience of health defined as the state of
well being perceived by an individual, this
concept is less valid when health is evalu-
ated in terms of physiological homeosta-
sis. Here, I will introduce the notion that
healthy cells are actively involved in sig-
naling for the presence of health, as con-
trasted to the widely accepted concept that
stressed cells send out messages indicat-
ing lack of health. I propose that, although
true at the level of human beings feel-
ing the state of their own health, Diderot’s
view that “When we are well, no part
of the body informs us of its existence”
(2) does not apply to the physiology of
cells, tissues, organs, and the body as a
whole.
MESSAGES OF DISTRESS
It is a widely accepted notion that cells sub-
jected to stress – be it of a physical, chem-
ical, metabolic, infectious or other origin –
react through a coordinated response that
leads to production of signals commu-
nicating the presence of stress and dan-
ger to other cells. These pathways have
been magistrally defined and delineated
by Chovatiya and Medzhitov in a recent
article (3). The end result of the elabo-
ration and propagation of signals of dis-
tress is the molecular, functional and struc-
tural reconfiguration of cells and tissues
to face conditions of lack of health and
eventually promote the return to home-
ostasis if and when the injurious stim-
ulus is removed, or to chronicization if
the stimulus persists. Examples of such
responses include increase in vascular per-
meability and induction of inflammatory
infiltrates, development of insulin resis-
tance, degradation of bone and cartilage,
disruption of the gut epithelial barrier,
altered neuronal function, inappropriately
increased or decreased cell proliferation or
cell death, development of fibrosis, and
many more.
The notion of the body responding to
lack of health by generating signals of
distress has been extremely productive in
furthering our understanding of mecha-
nisms of disease and developing thera-
peutic strategies. However, although not
explicitly stated, this view implies that,
whereas disease makes a lot of noise, health
is mostly silent.
MESSAGES OF HEALTH
But silent health is not. I propose that avail-
ability of messages of health is at least as
important in determining the state of an
organism as is the intensity of messages
of distress. Although much has been writ-
ten to define and classify these latter, a
comparable effort is lacking for messages
of health. This situation perhaps results
from the unstated, and for the most part
unconscious, belief of scientists that, again
with Canguilhem, “If health is life in the
silence of the organs, then, strictly speak-
ing, there is no science of health. Health is
organic innocence. It must be lost, like all
innocence, so that knowledge may be possi-
ble” (1). Though conceivable at the philo-
sophical level, physiological health does not
have much to do with innocence but is
rather the result of highly sophisticated,
coordinated, active biological strategizing
that can and should be studied as part
of a science of health. I believe we can
approach biomedical research from the
point of view of studying what improves
health in addition to, but not as a substi-
tute of, investigating what causes disease.
Identifying and understanding the nature
and regulation of messages of health would
be central to this enterprise, part of the
larger task, highlighted by Chovatiya and
Medzhitov, aimed at defining what consti-
tutes homeostasis at the tissue and organ
level (3).
I define messages of health as mole-
cules produced and released by healthy,
unstressed cells and whose presence con-
tributes to support a healthy organism.
Levels and/or activity of messages of health
are decreased in response to stress and
this reduction contributes to pathogene-
sis, thus providing a mirror image to the
behavior of messages of distress. This def-
inition is based on the properties of the
adipokine adiponectin, a protein produced
and released by adipocytes (4, 5). The
small adipocytes of a lean, insulin-sensitive
individual without cardiovascular disease,
particularly if this person is a woman,
produce high levels of adiponectin, high
enough to reach circulating levels in the
tens of micrograms per milliliter range.
Thus, healthy adipocytes spend a consid-
erable amount of energy (in the form of
ATP) and matter (in the form of amino
acids) to produce tremendous amounts of
adiponectin. Signaling by this adipokine in
a variety of organs is critical in maintain-
ing metabolic and vascular health and pro-
viding an overall anti-inflammatory tone
(4, 5). According to the above defini-
tion, stress should lead to reduced lev-
els or activity of messages of health; this
can occur secondary to decreased gene
expression or through alterations in the
processes of post-transcriptional and/or
post-translational modifications, reduced
release into the extra-cellular space as
well as diminished bioavailability and
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bioactivity. Indeed, exposure to a vari-
ety of stresses reduces adiponectin pro-
duction, both in vitro and in vivo (4, 5).
In obesity, as adipose tissue expands and
adipocytes become larger and as glucose
intolerance and insulin resistance develop,
production of adiponectin significantly
declines. Moreover,obesity is not only asso-
ciated with reduced adiponectin mRNA
and protein levels but also with alterations
in its multimerization properties, trans-
port across endothelium as well as per-
haps development of adiponectin resis-
tance (4–7). Evidence indicates that the
decreased adiponectin levels and activity
that accompany obesity, diabetes and car-
diovascular disease can be both cause and
effect of these pathologies (4, 5). More-
over, polymorphisms in the adiponectin
gene that affect rate of production, release
and ability to multimerize are associated
with risk of developing metabolic dis-
ease (4–7). Thus, adiponectin’s produc-
tion and activity are maximal under con-
ditions of health and are reduced by
stress, with this reduction causally con-
tributing to the pathogenesis of metabolic
diseases.
Is adiponectin’s biology unique? Can
the definition of messages of health be
applied to other molecules? Potential can-
didates exist, though they have not been
as extensively studied as adiponectin and
therefore not as many facets of their biol-
ogy are currently known. Osteocalcin is
a small protein produced and released by
osteoblasts; it is stored in the bone matrix
and is released into the circulation as
bone gets physiologically remodeled, act-
ing as an endocrine hormone. Osteocalcin
exerts beneficial effects on systemic glucose
and lipid metabolism, inhibits inflamma-
tion, and supports production of testos-
terone (8, 9). In humans, circulating lev-
els of osteocalcin are negatively corre-
lated with markers of the metabolic syn-
drome and diabetes, while limited evi-
dence supports the association between
genetic variants in osteocalcin and its
receptors and dysregulated glucose metab-
olism (8, 9). Another candidate message
of health is Klotho, aptly named after
the Greek Fate spinning the thread of
life (10). Klotho (α Klotho, to be pre-
cise) is mainly produced by the kidney and
exists as both a cell-associated and a solu-
ble protein, generated by either alternative
splicing or ectodomain shedding of the
membrane-bound form. Soluble Klotho
has a variety of salutary effects, including
regulation of insulin release, inhibition of
insulin growth factor signaling, protection
from cell senescence, modulation of renal
function and prevention of renal fibrosis,
maintenance of vascular health and down-
regulation of inflammatory responses (9,
11, 12). In keeping with the concept that
messages of health are reduced by stress,
levels of soluble Klotho are low in peo-
ple with diabetes (13) and decline with
age (14).
As these examples illustrate, messages
of health are molecules that are optimally
produced, released and bioactive in the
absence of stress and that communicate the
presence of health – or lack of distress –
however one prefers to frame the concept.
To be sure, flexibility is essential when con-
ceptualizing a molecule as a message of
health or distress, as crossover situations
are not that rare and can occur in either
direction. On the side of messages of health
turned into signals of distress we find, for
example, adiponectin levels being elevated
in some chronic conditions and possibly
contributing to disease pathogenesis (15),
while on the opposite side of the coin
one can mention, among several options,
the pro-inflammatory cytokine TNFα hav-
ing both beneficial and detrimental effects
in the intestinal environment (16) and
the alarmin HMGB1 promoting autophagy
and maintaining telomere integrity (17).
As always, context is crucial and catego-
rizations need to be taken with a grain
of salt. However, with these qualifications
in mind, molecules that are for the most
part produced and released by healthy cells
and carry messages of health can be dis-
tinguished from those that are generally
produced under conditions of distress and
signal for lack of health. Even though we
have a relatively good understanding of the
molecular pathways that signal for the pres-
ence of distress, the concept of messages
of health has not yet been formally pro-
posed and therefore identification, charac-
terization and categorization of these mol-
ecules is lagging behind. As a consequence,
at present the sound of health is still a
whisper, and a major challenge ahead will
be to understand whether it consists of
a simple melody or is instead a glorious
symphony.
THE SOUND OF SILENCE
Despite being biologically unrelated, the
notion of messages of health owes much
to the concept of resolution of inflam-
mation, defined as the “coordinated and
active process aimed at restoration of tis-
sue integrity and function” following an
inflammatory insult (18). Here, the stress
of inflammation induces production of
mediators that actively suppress the inflam-
matory response, a process that can poten-
tially be exploited through interventions
aimed at increasing synthesis or activity of
mediators of resolution, as opposed to the
traditional approach of suppressing pro-
duction of pro-inflammatory factors. As
indicated by the authors, “to transfer con-
cepts of resolution from bench to bedside
requires a shift in emphasis from inhibitory
therapy to replacement therapy, i.e., from
antagonism to agonism” (18). Messages of
health are, by definition, inhibited by stress
and therefore do not overlap with medi-
ators of resolution. However, the concept
of promoting production and activity of
messages of health instead of inhibiting
messages of distress, of using agonist rather
than antagonist approaches, is consistent
with the strategies proposed in the field
of resolution. A science of health could
thus lead to identification and characteri-
zation of additional messages of health and
to design and implementation of strategies
aimed at actively promoting health.
It is not simply the absence of signals of
distress that allows for Leriche’s “silence of
the organs,” but also the presence of mes-
sages of health, of molecules that form the
biological notes of that awesome sound of
silence we call health.
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